21.11
price down icon0.85%   -0.18
after-market 시간 외 거래: 21.11
loading
전일 마감가:
$21.29
열려 있는:
$21.13
하루 거래량:
922.33K
Relative Volume:
1.01
시가총액:
$1.37B
수익:
-
순이익/손실:
$-107.85M
주가수익비율:
-9.552
EPS:
-2.21
순현금흐름:
$-106.82M
1주 성능:
-1.81%
1개월 성능:
-22.05%
6개월 성능:
-48.37%
1년 성능:
-44.45%
1일 변동 폭
Value
$20.84
$21.90
1주일 범위
Value
$20.59
$21.90
52주 변동 폭
Value
$18.53
$51.61

베라 테라 Stock (VERA) Company Profile

Name
명칭
Vera Therapeutics Inc
Name
전화
650-770-0077
Name
주소
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Name
직원
112
Name
트위터
Name
다음 수익 날짜
2024-08-08
Name
최신 SEC 제출 서류
Name
VERA's Discussions on Twitter

VERA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
VERA
Vera Therapeutics Inc
21.11 1.37B 0 -107.85M -106.82M -2.21
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

베라 테라 Stock (VERA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-04 개시 Wolfe Research Outperform
2025-01-28 개시 Goldman Buy
2024-11-21 개시 Wells Fargo Overweight
2024-10-16 개시 Scotiabank Sector Outperform
2024-01-25 개시 Oppenheimer Outperform
2024-01-08 개시 Cantor Fitzgerald Overweight
2023-12-18 개시 Raymond James Outperform
2023-11-10 업그레이드 Jefferies Hold → Buy
2023-08-16 개시 Guggenheim Buy
2023-01-04 다운그레이드 Jefferies Buy → Hold
2023-01-04 다운그레이드 Wedbush Outperform → Neutral
2022-07-12 개시 JP Morgan Overweight
2022-05-02 개시 H.C. Wainwright Buy
2022-04-19 개시 Wedbush Outperform
모두보기

베라 테라 주식(VERA)의 최신 뉴스

pulisher
Apr 19, 2025

When (VERA) Moves Investors should Listen - news.stocktradersdaily.com

Apr 19, 2025
pulisher
Apr 18, 2025

Alliancebernstein L.P. Boosts Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Apr 18, 2025
pulisher
Apr 18, 2025

Vera Therapeutics (VERA) Stock Sees After-Market Boost - Stocks Telegraph

Apr 18, 2025
pulisher
Apr 15, 2025

Wellington Management Group LLP Trims Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Apr 15, 2025
pulisher
Apr 15, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by JPMorgan Chase & Co. - Defense World

Apr 15, 2025
pulisher
Apr 11, 2025

Polycythemia Vera Market to Show Remarkable Growth Trends from - openPR.com

Apr 11, 2025
pulisher
Apr 11, 2025

Polycythemia Vera Therapeutics Market Set to Witness - openPR.com

Apr 11, 2025
pulisher
Apr 09, 2025

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Apr 09, 2025
pulisher
Apr 09, 2025

Kidney Disease-Focused Vera Therapeutics Concludes Enrollment In Pivotal Study, Targets 2026 Commercial Launch - Yahoo Finance

Apr 09, 2025
pulisher
Apr 09, 2025

Vanguard Group Inc. Acquires 369,387 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Apr 09, 2025
pulisher
Apr 06, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Purchased by Corebridge Financial Inc. - Defense World

Apr 06, 2025
pulisher
Apr 06, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Consensus Rating of “Buy” from Analysts - Defense World

Apr 06, 2025
pulisher
Apr 05, 2025

KLP Kapitalforvaltning AS Makes New Investment in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Apr 05, 2025
pulisher
Apr 03, 2025

Vera Therapeutics completes enrollment for IgAN drug trial By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

Vera Therapeutics stock hits 52-week low at $21.44 By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

Vera Therapeutics stock hits 52-week low at $21.44 - Investing.com India

Apr 03, 2025
pulisher
Apr 03, 2025

Vera Therapeutics completes enrollment for IgAN drug trial - Investing.com Australia

Apr 03, 2025
pulisher
Apr 03, 2025

Vera Therapeutics completes enrollment in ORIGIN Phase 3 trial for atacicept - TipRanks

Apr 03, 2025
pulisher
Apr 03, 2025

Vera Therapeutics Completes Full Enrollment in Pivotal ORIGIN Phase 3 Trial for Atacicept in IgAN - GlobeNewswire

Apr 03, 2025
pulisher
Apr 02, 2025

Is Vera Therapeutics Inc (VERA) a threat to investors? - uspostnews.com

Apr 02, 2025
pulisher
Apr 01, 2025

Teacher Retirement System of Texas Acquires 3,942 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

Vera Therapeutics (NASDAQ:VERA) Reaches New 1-Year LowWhat's Next? - MarketBeat

Mar 31, 2025
pulisher
Mar 29, 2025

69,724 Shares in Vera Therapeutics, Inc. (NASDAQ:VERA) Bought by Raymond James Financial Inc. - Defense World

Mar 29, 2025
pulisher
Mar 26, 2025

Vera Therapeutics stock hits 52-week low at $25.97 By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Vera Therapeutics stock hits 52-week low at $25.97 - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Vera Therapeutics validates Fair Value bearish call with 42% decline By Investing.com - Investing.com UK

Mar 26, 2025
pulisher
Mar 26, 2025

Swiss National Bank Purchases 15,700 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Relative Strength Alert For Vera Therapeutics - Nasdaq

Mar 25, 2025
pulisher
Mar 22, 2025

AlphaQuest LLC Takes Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Mar 22, 2025
pulisher
Mar 20, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by Charles Schwab Investment Management Inc. - Defense World

Mar 20, 2025
pulisher
Mar 17, 2025

Bank of New York Mellon Corp Acquires 7,895 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Mar 17, 2025
pulisher
Mar 14, 2025

Is Vera Therapeutics (NASDAQ:VERA) Weighed On By Its Debt Load? - simplywall.st

Mar 14, 2025
pulisher
Mar 14, 2025

Victory Capital Management Inc. Increases Stake in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Recommendation of “Buy” by Analysts - Defense World

Mar 12, 2025
pulisher
Mar 12, 2025

Vera Therapeutics (VERA) Expected to Announce Quarterly Earnings on Wednesday - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Vera Therapeutics Growth Accelerates: 9 Strategic Hires Secure Equity Package Worth $2.3M - StockTitan

Mar 11, 2025
pulisher
Mar 11, 2025

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MENAFN.COM

Mar 11, 2025
pulisher
Mar 08, 2025

What is HC Wainwright’s Estimate for VERA FY2025 Earnings? - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Vera Therapeutics: Does The Earlier Otsuka Launch Harm Its Prospects Much? - Seeking Alpha

Mar 07, 2025
pulisher
Mar 07, 2025

Cantor Fitzgerald Analysts Lower Earnings Estimates for VERA - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

JPMorgan Chase & Co. Has Lowered Expectations for Vera Therapeutics (NASDAQ:VERA) Stock Price - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Vera Therapeutics (NASDAQ:VERA) Price Target Cut to $71.00 by Analysts at JPMorgan Chase & Co. - Armenian Reporter

Mar 05, 2025
pulisher
Mar 04, 2025

Vera Therapeutics Getting Closer To Key Technical Benchmark - MSN

Mar 04, 2025
pulisher
Mar 03, 2025

Rhumbline Advisers Has $2.48 Million Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Mar 03, 2025
pulisher
Mar 03, 2025

Q1 EPS Estimates for Vera Therapeutics Boosted by Wedbush - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

(VERA) On The My Stocks Page - news.stocktradersdaily.com

Mar 02, 2025
pulisher
Mar 02, 2025

What is Wedbush’s Forecast for VERA FY2029 Earnings? - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

Guggenheim Raises Vera Therapeutics (NASDAQ:VERA) Price Target to $61.00 - Defense World

Mar 01, 2025

베라 테라 (VERA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
자본화:     |  볼륨(24시간):